TRINITY MEDICAL GROUP INC
10QSB, EX-27.1, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: TRINITY MEDICAL GROUP INC, 10QSB, EX-4.7, 2000-11-14
Next: TRUE HEALTH INC, 10QSB, 2000-11-14



<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
FINANCIAL STATEMENTS OF TRINITY MEDICAL GROUP USA, INC. FOR THE NINE MONTHS
ENDED SEPTEMBER 30, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                       9-MOS
<FISCAL-YEAR-END>              DEC-31-2000
<PERIOD-START>                 JAN-01-2000
<PERIOD-END>                   SEP-30-2000
<CASH>                            113,356
<SECURITIES>                            0
<RECEIVABLES>                      20,000
<ALLOWANCES>                            0
<INVENTORY>                             0
<CURRENT-ASSETS>                  152,307
<PP&E>                              4,972
<DEPRECIATION>                          0
<TOTAL-ASSETS>                    157,279
<CURRENT-LIABILITIES>           1,545,513
<BONDS>                                 0
                   0
                             0
<COMMON>                           10,226
<OTHER-SE>                     (1,398,460)
<TOTAL-LIABILITY-AND-EQUITY>      157,279
<SALES>                                 0
<TOTAL-REVENUES>                        0
<CGS>                                   0
<TOTAL-COSTS>                   1,275,937
<OTHER-EXPENSES>                        0
<LOSS-PROVISION>                        0
<INTEREST-EXPENSE>                 55,495
<INCOME-PRETAX>                (1,331,432)
<INCOME-TAX>                            0
<INCOME-CONTINUING>                     0
<DISCONTINUED>                          0
<EXTRAORDINARY>                         0
<CHANGES>                               0
<NET-INCOME>                   (1,331,432)
<EPS-BASIC>                         (0.13)
<EPS-DILUTED>                       (0.13)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission